Please login to the form below
Chugai
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.
The flexible salesforce
By contrast, rates in Japan have not gone above 3% in 2020, in Germany they peaked at 8% and are now down to 3% and in the UK the peak of
Gavi says 76 wealthy countries have committed to COVAX vaccine facility
According to Berkley, over 70 nations have now signed up to the facility, including Japan, Norway and Germany, to procure vaccines through the COVAX facility for their respective nations.
Takeda to sell Japan consumer health unit for $2.3bn
Deal helps to reduce debt accrued from Shire takeover. Takeda is on the verge of selling its consumer health unit in Japan for up to $2.3bn to Blackstone Group, an
Roche’s Soliris rival Enspryng bags FDA approval
The new NMOSD treatment was originally designed by Roche’s Japanese subsidiary Chugai, using novel recycling antibody technology.
Gut instincts lead Takeda to GI pipeline success
Our motivation is clear. IBD has also been on the rise even in places where historically it didn’t have much of an impact, such as China, Japan, South-East Asia
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- Send Us a Message
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Keytruda doubles five-year survival rate in NSCLC
- Researchers call on Pfizer to delay COVID-19 vaccine application
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Covid-19 redefines rules of customer engagement
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Aurora extends exclusive collaboration with Patient Intelligence Panel (PIP Health)
- Moderna’s COVID-19 vaccine generates strong immune response in older adults
- Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms
- What makes a great launch leader and launch team?
PMHub
Wordbird
Wordbird is a healthcare communications agency with creative, compelling copy at its heart....
Latest intelligence
- Covid-19 redefines rules of customer engagement
- Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
- The concordance conundrum: understanding the complexities of behaviour change
- Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
Quick links
Infographics
